Analysts project a revenue dip and a reduced price target fo...
Analysts project a revenue dip and a reduced price target for Maravai LifeSciences Holdings. Increased investor caution may apply due to expected underperformance.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Analysts Just Slashed Next Year's Revenue Estimates By 17%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment